APPLIED DNA SCIENCES INC's ticker is APDNW and the CUSIP is 03815U110. A total of 1 filers reported holding APPLIED DNA SCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | -100.0% | 133,740 | +3.7% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 129,000 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 129,000 | +37.2% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 94,000 | +0.5% | 0.00% | – |
| Q3 2018 | $24,000 | -4.0% | 93,500 | +5.6% | 0.00% | – |
| Q2 2018 | $25,000 | +13.6% | 88,500 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | -31.2% | 88,500 | 0.0% | 0.00% | – |
| Q4 2017 | $32,000 | -48.4% | 88,500 | 0.0% | 0.00% | – |
| Q3 2017 | $62,000 | +77.1% | 88,500 | +0.8% | 0.00% | – |
| Q2 2017 | $35,000 | -2.8% | 87,800 | 0.0% | 0.00% | – |
| Q1 2017 | $36,000 | -7.7% | 87,800 | +12.9% | 0.00% | – |
| Q4 2016 | $39,000 | -55.7% | 77,800 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $88,000 | +1.1% | 77,800 | +2.4% | 0.00% | 0.0% |
| Q2 2016 | $87,000 | -35.1% | 76,000 | +3.0% | 0.00% | 0.0% |
| Q1 2016 | $134,000 | +12.6% | 73,800 | +4.5% | 0.00% | 0.0% |
| Q4 2015 | $119,000 | -33.9% | 70,600 | +17.7% | 0.00% | -50.0% |
| Q3 2015 | $180,000 | +114.3% | 60,000 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $84,000 | +33.3% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $63,000 | -13.7% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $73,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL AMERICAN INVESTORS CO INC | 281,409 | $472,000 | 0.04% |
| Ionic Capital Management LLC | 349,859 | $587,000 | 0.04% |
| Benchmark Capital Advisors | 10,000 | $17,000 | 0.01% |
| Creative Planning | 70,600 | $119,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 36,771 | $62,000 | 0.00% |
| NEXT Financial Group, Inc | 1,000 | $1,000 | 0.00% |